Literature DB >> 22360732

Developing and delivering clinical toxicology in the UK National Health Service.

Simon H L Thomas1.   

Abstract

Clinical toxicology concerns the investigation, diagnosis and management of suspected poisoning. It is an important discipline because of the frequency of suspected poisoning, including drug overdose. In the UK, most episodes are managed by nonspecialists, with support provided online or by telephone from the National Poisons Information Service. Leadership and clinical support for this is provided by a small number of clinical toxicologists, who are almost invariably accredited specialists in clinical pharmacology and therapeutics. Priorities for maintaining and enhancing clinical toxicology as a subspeciality in the UK include: 1 Maintaining funding for poisons centres. This is essential in spite of current budgetary pressures. 2 Formal training in the discipline. The 1 year optional training module in clinical toxicology approved in 2011 as part of the clinical pharmacology and therapeutics curriculum represents important progress, but funding for appropriate programmes and accreditation for trainees from other relevant disciplines is needed. Arrangements for registration and revalidation are also required. 3 An improved evidence base for management of poisoning. Priority areas include continued surveillance of the epidemiology and outcomes of poisoning, including syndromic surveillance, more rapid characterization of the human toxicity of newly introduced medicines and better clinical evidence on use of antidotes and other treatments; for example, acetylcysteine and lipid emulsion therapy.
© 2012 The Author. British Journal of Clinical Pharmacology © 2012 The British Pharmacological Society.

Entities:  

Mesh:

Year:  2012        PMID: 22360732      PMCID: PMC3391512          DOI: 10.1111/j.1365-2125.2012.04229.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  6 in total

1.  Cost-effectiveness of regional poison control centers.

Authors:  D L Harrison; J R Draugalis; M K Slack; P C Langley
Journal:  Arch Intern Med       Date:  1996 Dec 9-23

2.  Costs of poisoning in the United States and savings from poison control centers: a benefit-cost analysis.

Authors:  T R Miller; D C Lestina
Journal:  Ann Emerg Med       Date:  1997-02       Impact factor: 5.721

3.  Poison control centers: can their value be measured?

Authors:  W D King; P A Palmisano
Journal:  South Med J       Date:  1991-06       Impact factor: 0.954

4.  Cost saving from poison center use by medical consumers.

Authors:  R J Geller; R W Looser
Journal:  Vet Hum Toxicol       Date:  1985-12

5.  Detailed analyses of self-poisoning episodes presenting to a large regional teaching hospital in the UK.

Authors:  Katherine Prescott; Richard Stratton; Anette Freyer; Ian Hall; Ivan Le Jeune
Journal:  Br J Clin Pharmacol       Date:  2009-08       Impact factor: 4.335

6.  Multiple-dose activated charcoal in acute self-poisoning: a randomised controlled trial.

Authors:  Michael Eddleston; Edmund Juszczak; Nick A Buckley; Lalith Senarathna; Fahim Mohamed; Wasantha Dissanayake; Ariyasena Hittarage; Shifa Azher; K Jeganathan; Shaluka Jayamanne; Mh Rezvi Sheriff; David A Warrell
Journal:  Lancet       Date:  2008-02-16       Impact factor: 79.321

  6 in total
  2 in total

1.  Research priorities in biomarkers and surrogate end-points.

Authors:  Jeffrey K Aronson
Journal:  Br J Clin Pharmacol       Date:  2012-06       Impact factor: 4.335

2.  Inpatient toxicology services improve resource utilization for intoxicated patients: a systematic review.

Authors:  Robert G Legg; Mark Little
Journal:  Br J Clin Pharmacol       Date:  2018-10-28       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.